Literature DB >> 3818975

Reduced in vitro erythroid progenitor cell growth in bronchial cancer.

G S Masters, P Baines, R Bailey-Wood, T Gorvett, T Littlewood, P Bentley, H Parry-Jones, A Jacobs.   

Abstract

Peripheral blood and bone marrow were studied in 21 men with disseminated untreated bronchial cancer in an attempt to define abnormalities of erythropoiesis associated with the development of anaemia. Haemoglobin concentration at or below 13 g/dl was present in 13 cases. Marrow morphology was normal in all cases except one, in which small numbers of tumour cells were found. Clonal assay of erythroid progenitors showed a significant decrease in the number of BFU-E (p = 0.03) and CFU-E (p = 0.01) compared with cultures from normal marrow (12 subjects). The growth of granulocyte and macrophage progenitors (GM-CFCs) was similar in patients with bronchial cancer and normal subjects. When normal marrow was incubated in the presence of serum from bronchial cancer patients, no inhibitory factors could be detected either for BFU-E or CFU-E growth. In all patients circulating T8 numbers were significantly raised (p = 0.0002). Consequently, the median T4:T8 ratio in blood was 1.2, and this was significantly lower than the ratio of 1.7 found in 20 normal subjects (p = 0.036). In 18 patients the bone marrow T4:T8 ratio of 1.1 was significantly lower than the ratio of 2.9 found in seven normal subjects (p = 0.04). Total blood white cell counts, neutrophils, and monocyte numbers were also increased (p = 0.0001; p = 0.0001; p = 0.002).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3818975      PMCID: PMC1140835          DOI: 10.1136/jcp.40.1.87

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  25 in total

1.  Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells.

Authors:  A W Burgess; E M Wilson; D Metcalf
Journal:  Blood       Date:  1977-04       Impact factor: 22.113

2.  Interaction of lactoferrin, monocytes, and T lymphocyte subsets in the regulation of steady-state granulopoiesis in vitro.

Authors:  G C Bagby; V D Rigas; R M Bennett; A A Vandenbark; H S Garewal
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

3.  In vitro suppression of erythropoiesis by bone marrow adherent cells from some patients with fungal infection.

Authors:  E D Zanjani; P B McGlave; S F Davies; M Banisadre; M E Kaplan; G A Sarosi
Journal:  Br J Haematol       Date:  1982-03       Impact factor: 6.998

4.  Serum level of erythropoietin in anemias associated with chronic infection, malignancy, and primary hematopoietic disease.

Authors:  H P Ward; J E Kurnick; M J Pisarczyk
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

5.  The anemia of chronic disorders: studies of marrow regulation and iron metabolism.

Authors:  S W Douglas; J W Adamson
Journal:  Blood       Date:  1975-01       Impact factor: 22.113

6.  Erythropoiesis in the anaemia of rheumatoid arthritis.

Authors:  I Cavill; D P Bentley
Journal:  Br J Haematol       Date:  1982-04       Impact factor: 6.998

7.  Inhibition of erythroid colony formation by autologous bone marrow adherent cells from patients with the anemia of chronic disease.

Authors:  G D Roodman; V W Horadam; T L Wright
Journal:  Blood       Date:  1983-08       Impact factor: 22.113

8.  Studies of T-lymphocytes in preleukemic disorders and acute nonlymphocytic leukemia: in vitro radiosensitivity, mitogenic responsiveness, colony formation, and enumeration of lymphocytic subpopulations.

Authors:  S J Knox; B R Greenberg; R W Anderson; L S Rosenblatt
Journal:  Blood       Date:  1983-03       Impact factor: 22.113

9.  Anaemia in patients with myelomatosis.

Authors:  W C Ting; I Cavill; A Jacobs; S Kaaba; A May; S Smith; J A Whittaker
Journal:  Br J Cancer       Date:  1982-06       Impact factor: 7.640

10.  Erythropoiesis and iron metabolism in Hodgkin's disease.

Authors:  S Al-Ismail; I Cavill; I H Evans; A Jacobs; C Ricketts; D Trevett; J A Whittaker
Journal:  Br J Cancer       Date:  1979-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.